+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bone Growth Stimulators Market by Product (Platelet-Rich Plasma, Bone growth Stimulation Devices), Application, End User, and by Region - Global Forecast to 2022-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717264
The bone growth stimulators market size is estimated to be USD 1,807.1 million in 2022 and is expected to witness a CAGR of 5.87% during the forecast period 2023-2033. Rising choice of patients for non-invasive and minimally invasive surgical treatments, increasing prevalence of target disorders, and the escalating number of sports and accident-related orthopaedic injuries are factors contributing to the market growth. Furthermore, growing geriatric population and rising rates of osteoporosis and osteoarthritis However, inadequate healthcare reimbursement for bone stimulation devices and increased treatment costs of BMP and PRP products is expected to hinder the growth.

Increase in the number of trauma and accident cases.is also anticipated to fuel market expansion during the projected period. Approximately 41 million Americans visit the emergency room each year for treatment of serious injuries, according to the CDC. Road traffic accidents and other trauma are expected to result in a number of severe spinal injuries and fractures with delayed union and non-union that need surgical repair. By administering an ultrasonic or electrical current to the fusion site, these devices aid in the treatment of failed spinal fusions, delayed unions, fracture nonunion, and lately broken bones.

Growing geriatric population is also anticipated to fuel market expansion during the projected period. For instance, the National Center for Biotechnology Information projects that by 2050, Egypt will have 130 million people, more than 30% of whom would be over the age of 50. The percentage of the world's population that is 65 years of age or older is expected to increase from 10% in 2022 to 16% in 2050, according to the Centers for Disease Control and Prevention, which was published in May 2022. Furthermore, the World Health Organization reported in October 2021 that by the year 2020, there would be more adults aged 60 and older than children under the age of five.

Segmentation

By Product

The market is categorized into platelet-rich plasma (PRP), bone growth stimulation devices, bone morphogenetic proteins (BMP). In 2022, the bone growth stimulation devices segment accounted for the highest revenue share due to the surge in demand for minimally invasive surgical procedures for bone healing. These devices are also generally portable, battery-operated, light, and simple to use, which leads to an increase in their use by patients. Additionally, the availability of advanced devices including CMF SpinaLogic and OL1000 Bone Growth Stimulators is anticipated to accelerate market growth. Additionally, as external stimulator devices are less expensive than invasive internal devices, their uptake is expected to expand in developing nations like South Africa, India, and China. BMP and PRP segment is anticipated to develop profitably during the projected period due to the rise in cases of arthritis, spinal injuries, and trauma & accident.

By Application

The market is categorized into oral and maxillofacial surgeries, spinal fusion surgeries, delayed union & non-union bone fractures, and others. In the global market, the oral and maxillofacial surgeries segment accounted for the largest revenue share in 2022 owing to worldwide demand for spinal fusion surgery has grown as a result of a rise in the frequency of spinal cord injuries, including fractures, spinal stenosis, and herniated disc injuries. The WHO estimates that each year, between 250,000 and 500,000 people worldwide suffer spinal cord injuries, which are typically caused by car accidents, slips and falls, and violent acts. A further factor boosting the market is the rise in age-related spinal issues and fractures. Fractures and spinal issues are more likely to occur as a result of the decreased bone density and weakening of bones that come with ageing as a result of excessive bone mass loss. There is anticipated to be significant growth in the market for delayed union and non-union bone fractures throughout the study period. Osteoporosis is extremely common, which is predicted to drive market expansion. Osteoporosis can result in painful fractures and other serious health problems.

By End User

The market is segmented into home care, hospitals and clinics, and others. In 2022, the hospitals and clinics segment accounted for the largest revenue share owing to increase in patients being treated with traumatic injuries, injuries from auto accidents, spinal injuries, and fractures. Additionally, it is anticipated that the segment will rise as greater attention is paid to the construction of healthcare infrastructure in developing countries in the Asia Pacific and African regions. The accessibility of advanced medical devices for the treatment of various chronic diseases and rising disposable income are anticipated to increase the use of these items in hospitals and clinics. The homecare segment is predicted to grow profitably during the projection period due to product developments and growing public awareness of healthcare. Ambulatory surgical centres and research institutes comprise the other end-use segment. This segment is anticipated to experience profitable CAGR over the forecast period due to a significant increase in the quantity of spine fusion procedures carried out in ambulatory surgical facilities.

Regional Markets

In 2022, North America region accounted for the highest revenue in the bone growth stimulators market and is expected to maintain its dominance during the forecast period. This is attributed to the high incidence of osteoporosis or vertebral fractures. The American Association of Neurological Surgeons estimates that 8 million women in the United States have osteoporosis and that 25% of women are at risk for vertebral compression fractures (VCFs). Demand for bone growth stimulators used for improved healing has increased as a result of a rise in the incidence of osteoporosis and VCFs, which propels market expansion. Europe was the second-largest market for bone growth stimulators due to the increasing need for novel treatments for chronic conditions and the regional presence of top medical device manufacturers including Zimmer Biomet, Medtronic, Bioventus, Stryker, Orthofix Holdings, Inc., and Terumo BCT, Inc.

Competitor Insights

Some of the key players operating in the bone growth stimulators market are Ossatec Benelux BV, Orthofix International N.V., Elizur, Verve Consulting Inc., Medtronic, Plc., Bioventus LLC., Zimmer Biomet Holdings Inc., Arthrex, Inc., Precyse Solutions LLC., DJO LLC, and IGEA S.p.A.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

The AccelStim bone healing therapy Class III device received pre-market approval from the U.S. According to Orthofix Medical Inc., a medical device company with an emphasis on spine and orthopedics, the FDA approved the product in May 2022. In order to speed up the healing of fractures, the device produces a Low-Intensity Pulsed Ultrasound (LIPUS) signal that stimulates the bone's natural healing process. Through a targeted and phased launch strategy, it is projected that the commercial availability of the AccelStim device can take place in the second quarter of 2022.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, application, and end user from 2023 to 2033.

Segmentation: Bone Growth Stimulators Market Report 2022 - 2033

Product (Revenue, USD Million), 2022 - 2033

  • Platelet-Rich Plasma (PRP)

Bone growth Stimulation Devices

  • Ultrasonic Bone Growth Stimulators
  • Implanted Bone Growth Stimulators
  • External Bone Growth Stimulators
  • Pulsed Electromagnetic Field (PEMF) devices
  • Combined Magnetic Field (CMF) devices
  • Capacitive Coupling (CC) devices
  • Bone Morphogenetic Proteins (BMP)

Application (Revenue, USD Million), 2022 - 2033

  • Oral and Maxillofacial Surgeries
  • Spinal Fusion Surgeries
  • Delayed Union & Non-union Bone Fractures
  • Others

End user (Revenue, USD Million), 2022 - 2033

  • Home Care
  • Hospitals and clinics
  • Others

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Bone Growth Stimulators

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Bone Growth Stimulators Market

7. Market Analysis by Product
7.1. Platelet-Rich Plasma (PRP)
7.1.1. Platelet-Rich Plasma (PRP)
7.2. Bone growth Stimulation Devices
7.2.1. Bone growth Stimulation Devices
7.2.1.1. Ultrasonic Bone Growth Stimulators
7.2.1.1.1. Ultrasonic Bone Growth Stimulators Market Forecast, 2022-2033 (USD Million)
7.2.1.2. Implanted Bone Growth Stimulators
7.2.1.2.1. Implanted Bone Growth Stimulators Market Forecast, 2022-2033 (USD Million)
7.2.1.3. External Bone Growth Stimulators
7.2.1.3.1. External Bone Growth Stimulators Market Forecast, 2022-2033 (USD Million)
7.2.1.3.1.1. Pulsed Electromagnetic Field (PEMF) devices
7.2.1.3.1.1.1. Pulsed Electromagnetic Field (PEMF) devices Market Forecast, 2022-2033 (USD Million)
7.2.1.3.1.2. Combined Magnetic Field (CMF) devices
7.2.1.3.1.2.1. Combined Magnetic Field (CMF) devices Market Forecast, 2022-2033 (USD Million)
7.2.1.3.1.3. Capacitive Coupling (CC) devices
7.2.1.3.1.3.1. Capacitive Coupling (CC) devices Market Forecast, 2022-2033 (USD Million)
7.3. Bone Morphogenetic Proteins (BMP)
7.3.1. Bone Morphogenetic Proteins (BMP) Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Application
8.1. Oral and Maxillofacial Surgeries
8.1.1. Oral and Maxillofacial Surgeries Market Forecast, 2022-2033 (USD Million)
8.2. Spinal Fusion Surgeries
8.2.1. Spinal Fusion Surgeries Market Forecast, 2022-2033 (USD Million)
8.3. Delayed Union & Non-union Bone Fractures
8.3.1. Delayed Union & Non-union Bone Fractures Market Forecast, 2022-2033 (USD Million)
8.4. Others
8.4.1. Others Market Forecast, 2022-2033 (USD Million)

9. Market Analysis by End User
9.1. Home Care
9.1.1. Home Care Market Forecast, 2022-2033 (USD Million)
9.2. Hospitals and clinics
9.2.1. Hospitals and clinics Market Forecast, 2022-2033 (USD Million)
9.3. Others
9.3.1. Others Market Forecast, 2022-2033 (USD Million)

8. Regional Market Analysis
8.1. Regional Market Trends Analysis

9. North America Bone Growth Stimulators Market
9.1. North America Bone Growth Stimulators Market
9.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
9.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
9.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
9.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
9.2. U.S. Bone Growth Stimulators Market
9.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
9.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
9.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
9.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
9.3. Canada Bone Growth Stimulators Market
9.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
9.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
9.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
9.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

10. Europe Bone Growth Stimulators Market
10.1. Europe Bone Growth Stimulators Market
10.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.2. Germany Bone Growth Stimulators Market
10.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.3. UK Bone Growth Stimulators Market
10.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.4. France Bone Growth Stimulators Market
10.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
10.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.5. Spain Bone Growth Stimulators Market
10.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
10.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.6. Italy Bone Growth Stimulators Market
10.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
10.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.6.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.6.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.7. Rest of Europe Bone Growth Stimulators Market
10.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
10.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.7.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.7.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

11. Asia Pacific Bone Growth Stimulators Market
11.1. Asia Pacific Bone Growth Stimulators Market
11.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.2. Japan Bone Growth Stimulators Market
11.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.3. China Bone Growth Stimulators Market
11.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.4. India Bone Growth Stimulators Market
11.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.5. South Korea Bone Growth Stimulators Market
11.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.6. Australia Bone Growth Stimulators Market
11.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.6.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.7. Rest of Asia Pacific Bone Growth Stimulators Market
11.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.7.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

12. Latin America Bone Growth Stimulators Market
12.1. Latin America Bone Growth Stimulators Market
12.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.2. Brazil Bone Growth Stimulators Market
12.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.3. Mexico Bone Growth Stimulators Market
12.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.4. Argentina Bone Growth Stimulators Market
12.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.5. Rest of Latin America Bone Growth Stimulators Market
12.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

13. MEA Bone Growth Stimulators Market
13.1. MEA Bone Growth Stimulators Market
13.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.2. GCC Bone Growth Stimulators Market
13.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.3. South Africa Bone Growth Stimulators Market
13.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.4. Rest of MEA Bone Growth Stimulators Market
13.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

14. Competitor Analysis
14.1. Market Share Analysis, 2022
14.2. Major Recent Developments, 2019-2022

15. Company Profiles
15.1. Ossatec Benelux BV
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financial Analysis
15.1.4. Product Benchmarking
15.1.5. Recent Developments
15.2. Orthofix International N. V.
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financial Analysis
15.2.4. Product Benchmarking
15.2.5. Recent Developments
15.3. Elizur
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financial Analysis
15.3.4. Product Benchmarking
15.3.5. Recent Developments
15.4. Verve Consulting Inc.
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financial Analysis
15.4.4. Product Benchmarking
15.4.5. Recent Developments
15.5. Medtronic, Plc.
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financial Analysis
15.5.4. Product Benchmarking
15.5.5. Recent Developments
15.6. Bioventus LLC.
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financial Analysis
15.6.4. Product Benchmarking
15.6.5. Recent Developments
15.7. Zimmer Biomet Holdings Inc.
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financial Analysis
15.7.4. Product Benchmarking
15.7.5. Recent Developments
15.8. Arthrex, Inc.
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financial Analysis
15.8.4. Product Benchmarking
15.8.5. Recent Developments
15.9. Precyse Solutions LLC
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financial Analysis
15.9.4. Product Benchmarking
15.9.5. Recent Developments
15.10. DJO LLC
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financial Analysis
15.10.4. Product Benchmarking
15.10.5. Recent Developments
15.11. IGEA S. p. A.
15.11.1. Company Snapshot
15.11.2. Company Overview
15.11.3. Financial Analysis
15.11.4. Product Benchmarking
15.11.5. Recent Developments
15.12. Company 12
15.12.1. Company Snapshot
15.12.2. Company Overview
15.12.3. Financial Analysis
15.12.4. Product Benchmarking
15.12.5. Recent Developments
15.13. Company 13
15.13.1. Company Snapshot
15.13.2. Company Overview
15.13.3. Financial Analysis
15.13.4. Product Benchmarking
15.13.5. Recent Developments
15.14. Company 14
15.14.1. Company Snapshot
15.14.2. Company Overview
15.14.3. Financial Analysis
15.14.4. Product Benchmarking
15.14.5. Recent Developments
15.15. Company 15
15.15.1. Company Snapshot
15.15.2. Company Overview
15.15.3. Financial Analysis
15.15.4. Product Benchmarking
15.15.5. Recent Developments

16. Conclusion

17. Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Ossatec Benelux BV
  • Orthofix International N.V.
  • Elizur
  • Verve Consulting Inc.
  • Medtronic PLC.
  • Bioventus LLC.
  • Zimmer Biomet Holdings Inc.
  • Arthrex Inc.
  • Precyse Solutions LLC.
  • DJO LLC
  • IGEA S.p.A